Development of viral vectors for gene therapy for chronic pain

Pain Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Huang, Yu ^a   Liu, Xin ^b   Dong, Lanlan ^a   Liu, Zhongchun ^a   He, Xiaohua ^a,b   Liu, Wanhong ^a,b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873815967     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2011/968218     Document Type: Review

References (64)

1. Fink D. J., Mata M., HSV gene transfer in the treatment of chronic pain. Sheng Li Xue Bao 2008 60 5 610 616
2. Mata M., Hao S., Fink D. J., Applications of gene therapy to the treatment of chronic pain. Current Gene Therapy 2008 8 1 42 48 2-s2.0-41749121230 10.2174/156652308783688527 (Pubitemid 351485839)
3. Goins W. F., Goss J. R., Chancellor M. B., de Groat W. C., Glorioso J. C., Yoshimura N., Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Therapy 2009 16 4 558 569 2-s2.0-64549125138 10.1038/gt.2009.19
4. Pohl M., Braz J., Gene therapy of pain: emerging strategies and future directions. European Journal of Pharmacology 2001 429 1-3 39 48 2-s2.0-0035840843 10.1016/S0014-2999(01)01304-8 (Pubitemid 33043980)
5. Marshall E., Clinical research: gene therapy a suspect in leukemia-like disease. Science 2002 298 5591 34 35 2-s2.0-0037020112 10.1126/science.298.5591. 34
6. Marshall E., Gene therapy: second child in French trial is found to have leukemia. Science 2003 299 5605, article 320 2-s2.0-0037449534 10.1126/science.299.5605.320 (Pubitemid 36120006)
7. Dani S. U., The challenge of vector development in gene therapy. Brazilian Journal of Medical and Biological Research 1999 32 2 133 145 2-s2.0-0033073430 (Pubitemid 129606669)
8. Hao S., Mata M., Fink D. J., Viral vector-based gene transfer for treatment of chronic pain. International Anesthesiology Clinics 2007 45 2 59 71 2-s2.0-34247209700 10.1097/AIA.0b013e318034199c (Pubitemid 46624186)
9. Yeomans D. C., Lu Y., Laurito C. E., Peters M. C., Vota-Vellis G., Wilson S. P., Pappas G. D., Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia. Molecular Therapy 2006 13 3 589 597 2-s2.0-32944473702 10.1016/j.ymthe.2005.08.023 (Pubitemid 43257627)
10. Cope D. K., Lariviere W. R., Gene therapy and chronic pain. TheScientificWorldJournal 2006 6 1066 1074 2-s2.0-33748852245 10.1100/tsw.2006.197 (Pubitemid 44440818)
11. Berto E., Bozac A., Marconi P., Development and application of replication-incompetent HSV-1-based vectors. Gene Therapy 2005 12 1 S98 S102 2-s2.0-27544462820 10.1038/sj.gt.3302623 (Pubitemid 41541758)
12. Goins W. F., Goss J. R., Chancellor M. B., de Groat W. C., Glorioso J. C., Yoshimura N., Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Therapy 2009 16 4 558 569 2-s2.0-64549125138 10.1038/gt.2009.19
13. Wolfe D., Mata M., Fink D. J., A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Therapy 2009 16 4 455 460 2-s2.0-64549155264 10.1038/gt.2009.17
14. Goss J. R., Harley C. F., Mata M., O'Malley M. E., Goins W. F., Hu X., Glorioso J. C., Fink D. J., Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Annals of Neurology 2002 52 5 662 665 2-s2.0-0036829485 10.1002/ana.10343 (Pubitemid 35246874)
15. Goss J. R., Mata M., Goins W. F., Wu H. H., Glorioso J. C., Fink D. J., Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy 2001 8 7 551 556 2-s2.0-0035038249 10.1038/sj.gt.3301430 (Pubitemid 32409530)
16. Wilson S. P., Yeomans D. C., Bender M. A., Lu Y., Goins W. F., Glorioso J. C., Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3211 3216 2-s2.0-0033026831 10.1073/pnas.96.6.3211 (Pubitemid 29148870)
17. Braz J., Beaufour C., Coutaux A., Epstein A. L., Cesselin F., Hamon M., Pohl M., Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. Journal of Neuroscience 2001 21 20 7881 7888 2-s2.0-0035887602 (Pubitemid 32952747)
18. Hao S., Wolfe D., Glorioso J. C., Mata M., Fink D. J., djfink@umich.edu Effects of transgene-mediated endomorphin-2 in inflammatory pain. European Journal of Pain 2009 13 4 380 386 10.1016/j.ejpain.2008.05.008
19. Wolfe D., Hao S., Hu J., Srinivasan R., Goss J., Mata M., Fink D. J., Glorioso J. C., Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain 2007 133 1-3 29 38 2-s2.0-36148980321 10.1016/j.pain.2007.02.003 (Pubitemid 350138306)
20. Yokoyama H., Sasaki K., Franks M. E., Goins W. F., Goss J. R., De Groat W. C., Glorioso J. C., Chancellor M. B., Yoshimura N., Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Therapy 2009 20 1 63 71 2-s2.0-58849087513 10.1089/hum.2008.094
21. Meunier A., Latrémolière A., Mauborgne A., Bourgoin S., Kayser V., Cesselin F., Hamon M., Pohl M., Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. Molecular Therapy 2005 11 4 608 616 2-s2.0-14844339192 10.1016/j.ymthe.2004.12.011 (Pubitemid 40353118)
22. Hao S., Mata M., Goins W., Glorioso J. C., Fink D. J., Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003 102 1-2 135 142 2-s2.0-0037333714 10.1016/s0304-3959(02)00346-9 (Pubitemid 36298869)
23. Hao S., Mata M., Glorioso J. C., Fink D. J., HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Molecular Pain 2006 2 6 1 9 2-s2.0-33646409615 10.1186/1744-8069-2-6 (Pubitemid 43676911)
24. Peng X. M., Zhou Z. G., Glorioso J. C., Fink D. J., Mata M., Tumor necrosis factor-α contributes to below-level neuropathic pain after spinal cord injury. Annals of Neurology 2006 59 5 843 851 2-s2.0-33646379090 10.1002/ana.20855 (Pubitemid 43673162)
25. Hao S., Mata M., Wolfe D., Glorioso J. C., Fink D. J., Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Annals of Neurology 2005 57 6 914 918 2-s2.0-20444402960 10.1002/ana.20483 (Pubitemid 40798630)
26. Liu J., Wolfe D., Hao S., Huang S., Glorioso J. C., Mata M., Fink D. J., Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Molecular Therapy 2004 10 1 57 66 2-s2.0-3042730574 10.1016/j.ymthe.2004.04.017 (Pubitemid 38878149)
27. Yeomans D. C., Levinson S. R., Peters M. C., Koszowski A. G., Tzabazis A. Z., Gilly W. F., Wilson S. P., Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Na1.7 sodium channels in primary afferents. Human Gene Therapy 2005 16 2 271 277 2-s2.0-14844298657 10.1089/hum.2005.16.271 (Pubitemid 40344218)
28. Xu Y., Gu Y., Wu P., Li G. W., Huang L. Y. M., Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Human Gene Therapy 2003 14 9 897 906 2-s2.0-0038618928 10.1089/104303403765701187 (Pubitemid 36693798)
29. Manfredsson F. P., Mandel R. J., Development of gene therapy for neurological disorders. Discovery Medicine 2010 9 46 204 211 2-s2.0-77953722282
30. Ziello J. E., Huang Y., Jovin I. S., Cellular endocytosis and gene delivery. Molecular Medicine 2010 16 5-6 222 229 2-s2.0-77951956539 10.2119/molmed.2009.00101
31. Milligan E. D., Sloane E. M., Langer S. J., Cruz P. E., Chacur M., Spataro L., Wieseler-Frank J., Hammack S. E., Maier S. F., Flotte T. R., Forsayeth J. R., Leinwand L. A., Chavez R., Watkins L. R., Controlling neurophatic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Molecular Pain 2005 1 9 1 9 2-s2.0-27144459872 10.1186/1744-8069-1-9 (Pubitemid 44848613)
32. Kim S. J., Lee W. I., Lee Y. S., Kim D. H., Chang J. W., Kim S. W., Lee H., Effective relief of neuropathic pain by adeno-associated virus-mediated expression of a small hairpin RNA against GTP cyclohydrolase 1. Molecular Pain 2009 5 67 1 9 2-s2.0-75549086491
33. Xu Y., Gu Y., Xu G. Y., Wu P., Li G. W., Huang L. Y. M., Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception. Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6204 6209 2-s2.0-0038623685 10.1073/pnas.0930324100 (Pubitemid 36576954)
34. Storek B., Reinhardt M., Wang C., Janssen W. G. M., Harder N. M., Banck M. S., Morrison J. H., Beutler A. S., Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proceedings of the National Academy of Sciences of the United States of America 2008 105 3 1055 1060 2-s2.0-38949151650 10.1073/pnas.0708003105 (Pubitemid 351282080)
35. Eaton M. J., Blits B., Ruitenberg M. J., Verhaagen J., Oudega M., Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Therapy 2002 9 20 1387 1395 10.1038/sj.gt.3301814 (Pubitemid 35244164)
36. Zhou L.-J., Yang T., Wei X., Liu Y., Xin W.-J., Chen Y., Pang R.-P., Zang Y., Li Y.-Y., Liu X.-G., liuxg@mail.sysu.edu.cn Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat. Brain, Behavior, and Immunity 2011 25 2 322 334 10.1016/j.bbi.2010.09.025
37. Biggs J. E., JBiggs@pmcol.ualberta.ca Lu V. B., luvb@mail.nih.gov Stebbing M. J., martin.stebbing@rmit.edu.au Balasubramanyan S., sridhar@pmcol.ualberta.ca Smith P. A., peter.a.smith@ualberta.ca Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Molecular Pain 2010 6 44 1 14 10.1186/1744-8069-6-44
38. Zheng H., Qiao C., Wang C. H., Li J., Li J., Yuan Z., Zhang C., Xiao X., Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle. Human Gene Therapy 2010 21 1 87 97 2-s2.0-74949140217 10.1089/hum.2009.131
39. Pohl M., Fink D. J., A new player in gene therapy for pain? Gene Therapy 2008 15 13 953 954 10.1038/gt.2008.80 (Pubitemid 351865751)
40. Benihoud K., Yeh P., Perricaudet M., Adenovirus vectors for gene delivery. Current Opinion in Biotechnology 1999 10 5 440 447 2-s2.0-0032834927 10.1016/S0958-1669(99)00007-5 (Pubitemid 29457268)
41. Liu L., Wang S., Shan B., Sang M., Liu S., Wang G., Advances in viral-vector systemic cytokine gene therapy against cancer. Vaccine 2010 28 23 3883 3887 2-s2.0-77952423756 10.1016/j.vaccine.2010.03.041
42. Meisner J. G., Marsh A. D., Marsh D. R., Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. Journal of Neurotrauma 2010 27 4 729 737 2-s2.0-77951294191 10.1089/neu.2009.1166
43. Vit J. P., Ohara P. T., Sundberg C., Rubi B., Maechler P., Liu C., Puntel M., Lowenstein P., Castro M., Jasmin L., Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia. Molecular Pain 2009 5 42 1 11 2-s2.0-69849103229 10.1186/1744-8069-5-42
44. Finegold A. A., Mannes A. J., Iadarola M. J., A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Human Gene Therapy 1999 10 7 1251 1257 2-s2.0-0033135762 10.1089/ 10430349950018238 (Pubitemid 29231867)
45. Milligan E. D., Langer S. J., Sloane E. M., He L., Wieseler-Frank J., O'Connor K., Martin D., Forsayeth J. R., Maier S. F., Johnson K., Chavez R. A., Leinwand L. A., Watkins L. R., Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. European Journal of Neuroscience 2005 21 8 2136 2148 2-s2.0-21044459829 10.1111/j.1460-9568.2005.04057.x (Pubitemid 40695238)
46. Yao M. Z., Gu J. F., Wang J. H., Sun L. Y., Liu H., Liu X. Y., Adenovirus-mediated interleukin-2 gene therapy of nociception. Gene Therapy 2003 10 16 1392 1399 2-s2.0-0043026994 10.1038/sj.gt.3301992 (Pubitemid 36987130)
47. Yao M. Z., Gu J. F., Wang J. H., Sun L. Y., Lang M. F., Liu J., Zhao Z. Q., Liu X. Y., Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002 112 2 409 416 2-s2.0-0037129964 10.1016/S0306-4522(02)00078-7 (Pubitemid 34607024)
48. Federici T., Kutner R., Zhang X. Y., Kuroda H., Tordo N., Boulis N. M., Reiser J., Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer. Genetic Vaccines and Therapy 2009 7 1 1 9 2-s2.0-60749114487 10.1186/1479-0556-7-1
49. Meunier A., Mauborgne A., Masson J., Mallet J., Pohl M., Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development. Journal of Neuroscience Methods 2008 167 2 148 159 2-s2.0-36849049311 10.1016/j.jneumeth.2007.07.022 (Pubitemid 350235620)
50. Nagano M., Sakai A., Takahashi N., Umino M., Yoshioka K., Suzuki H., Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain. British Journal of Pharmacology 2003 140 7 1252 1260 2-s2.0-1642504333 10.1038/sj.bjp.0705550 (Pubitemid 38117430)
51. Pezet S., Krzyzanowska A., Wong L. F., Grist J., Mazarakis N. D., Georgievska B., McMahon S. B., Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. Molecular Therapy 2006 13 6 1101 1109 2-s2.0-33746234869 10.1016/j.ymthe.2005.11.026 (Pubitemid 44207843)
52. Meunier A., Latrémolière A., Dominguez E., Mauborgne A., Philippe S., Hamon M., Mallet J., Benoliel J. J., Pohl M., Lentiviral-mediated targeted NF- B blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Molecular Therapy 2007 15 4 687 697 2-s2.0-33947227317 10.1038/sj.mt.6300107 (Pubitemid 46431988)
53. Liu W., Liu Z., Cao X., Cao Z., Xue L., Zhu F., He X., Li W., Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes. Molecular Therapy 2007 15 10 1834 1841 10.1038/sj.mt.6300224 (Pubitemid 47434191)
54. Mergia A., Heinkelein M., Foamy virus vectors. Current Topics in Microbiology and Immunology 2003 277 131 159 2-s2.0-0012931669 (Pubitemid 36612744)
55. Trobridge G. D., Foamy virus vectors for gene transfer. Expert Opinion on Biological Therapy 2009 9 11 1427 1436 2-s2.0-70350633843 10.1517/ 14712590903246388
56. Liu W., Liu Z., Liu L., Xiao Z., Cao X., Cao Z., Xue LU., Miao L., He X., Li W., A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury. Neuroscience Letters 2008 432 1 13 18 2-s2.0-38749153918 10.1016/j.neulet.2007.11.054
57. Baron R., r.baron@neurologie.uni-kiel.de Binder A., Wasner G., Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurology 2010 9 8 807 819 10.1016/S1474-4422(10)70143-5
58. Watkins L. R., Hutchinson M. R., Ledeboer A., Wieseler-Frank J., Milligan E. D., Maier S. F., Glia as the «bad guys»: implications for improving clinical pain control and the clinical utility of opioids. Brain, Behavior, and Immunity 2007 21 2 131 146 2-s2.0-33845945382 10.1016/j.bbi.2006. 10.011 (Pubitemid 46038918)
59. Mata M., Glorioso J., Fink D. J., Development of HSV-mediated gene transfer for the treatment of chronic pain. Experimental Neurology 2003 184 1 S25 S29 2-s2.0-0242333885 10.1016/S0014-4886(03)00357-1 (Pubitemid 37338700)
60. Naik A. K., Pathirathna S., Jevtovic-Todorovic V., GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury. Neuroscience 2008 154 4 1539 1553 2-s2.0-45849100495 10.1016/j.neuroscience.2008.04.061
61. Freytag S. O., Khil M., Stricker H., Peabody J., Menon M., DePeralta-Venturina M., Nafziger D., Pegg J., Paielli D., Brown S., Barton K., Lu M., Aguilar-Cordova E., Kim J. H., Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Research 2002 62 17 4968 4976 2-s2.0-0036733759 (Pubitemid 34984421)
62. Habib N., Salama H., Abu Median A. A. E. L., Anis I. I., Al Aziz R. A. A., Sarraf C., Mitry R., Havlik R., Seth P., Hartwigsen J., Bhushan R., Nicholls J., Jensen S., Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Therapy 2002 9 3 254 259 2-s2.0-0036198603 10.1038/sj/cgt/7700431 (Pubitemid 34205499)
63. Khorana A. A., Rosenblatt J. D., Sahasrabudhe D. M., Evans T., Ladrigan M., Marquis D., Rosell K., Whiteside T., Phillippe S., Acres B., Slos P., Squiban P., Ross M., Kendra K., A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Therapy 2003 10 4 251 259 2-s2.0-0037385454 10.1038/sj.cgt.7700568 (Pubitemid 36423106)
64. Wolfe D., Wechuck J., Krisky D., Mata M., Fink D. J., A clinical trial of gene therapy for chronic pain. Pain Medicine 2009 10 7 1325 1330 2-s2.0-73949111798